Return to: Medical School : Academic Health Center : myAHC : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
IPTR masthead graphic
Whats Inside
Contact Us

About Us

Registry Staff

Annual Reports

IPTR Database

IPTR Links

Slide Library

 

IPTR Home

Home > Annual Reports > 2003 Annual Report > Effect of Diabetes Type on USA SPK Outcome for 1998 - 2003 Cases

Printer-friendly version   Mail this page to a friend

Effect of Diabetes Type on USA SPK Outcome for 1998 - 2003 Cases


Since 1994, transplant centers reported recipients as diabetes type 1 or type 2. Of 1999-2003 primary DD recipients, 6% SPK, 4% PAK and 3% PTA were classified by the reporting centers as type 2.  For SPK, mean recipient age range was 40+8 years for type 1 (n=3479) and 44+8 years for type 2 (n=231) (p=0.003).  Neither patient survival rates nor pancreas graft survival rates had statistically significant differences in SPK type 1 and type 2 cases.  For type 1, patient survival at 1 year was 95% and pancreas graft survival was 84.8%; for type 2, rates were 93% and 85.2% respectively. By HLA phenotype, DR 3 or 4 or both antigens was expressed in 51% of type 1 vs. 47% of type 2.

Previous page / Next page / Index


Feedback | Notice of Privacy Practices

 
The University of Minnesota is an equal opportunity educator and employer.